Site content: Global

Press Release

Menarini Silicon Biosystems’s CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2)...

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific...

Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB’s DEPArray technology* to successfully...

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive...

New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care

As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US...

Menarini’s CELLSEARCH® Circulating Endothelial Cells assay to monitor systemic sclerosis in clinical research studies: new data presented at the 2021 EULAR Congress

This non-invasive test leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Endothelial Cells from blood and may provide novel and valuable information on systemic...

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9...

Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies

The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers...

Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture

CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood   BOLOGNA, Italy and HUNTINGDON VALLEY,...
12345678